Omeros
在场
高管
查看带有其 19 名主要高管的组织结构图
Omeros 搜索最多的简介
高管在Omeros变化
- Michael Jacobsen, Vice President, Finance, Chief Accounting Officer and Treasurer, 将于 20246月30 退休 (新闻发布的2024六月13号).
- David Borges 曾任 Associate Vice President, Financial Planning & Analysis, 将于 20246月30 升职为 Vice President, Finance, Chief Accounting Officer and Treasure (新闻发布的2024六月13号).
创建提醒
跟踪 Omeros 的高管变动
药店
Omeros 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
Omeros 的最新新闻稿
- Omeros Corporation - Press Releases
- Omeros Corporation - Press Releases
- Omeros Corporation - myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab
- Omeros Corporation - Omeros’ Newly Presented GPR174 Immuno-oncology Data at ESMO Immuno-Oncology Congress Show Inhibition of Both Checkpoint and Tumor-Promoting Factors
- Omeros Corporation - Omeros Announces Full Exercise and Closing of Underwriter’s Option to Purchase Additional Shares
- Omeros Corporation - Omeros to Present GPR174 Data at the European Society for Medical Oncology 2019 Immuno-Oncology Congress in Geneva
- Omeros Corporation - Omeros Announces Pricing of Upsized Public Offering of Common Stock
- Omeros Corporation - Omeros Announces Proposed Public Offering of Common Stock
- Omeros Corporation - Omeros Reports Positive Data Across Primary and Secondary Endpoints in Pivotal Trial of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy Patients Treated with Narsoplimab
- Omeros Corporation - Omeros Corporation Reports Third Quarter 2019 Financial Results
- View more press releases Close
通过电子邮件
